Jazz Pharmaceuticals Plc(FRA) J7Z

Market Cap€13.98B

Since IPON/A

5 YearN/A

1 YearN/A

1 MonthN/A

€216.00

+2.18%

+4.60Today

Jazz Pharmaceuticals Plc Financials at a Glance

Market Cap

€13.98B

Revenue (TTM)

€3.95K

Net Income (TTM)

€806.28

EPS (TTM)

€12.43

P/E Ratio

17.33

Dividend

€0.00

Beta (Volatility)

-0.14 (Low)

Dividend

€0.00

Beta (Volatility)

-0.14 (Low)

Price

€216.00

Volume

Open

€208.40

Price

€216.00

Volume

Open

€208.40

Previous Close

€216.00

Daily Range

€208.40 - €216.60

52-Week Range

€106.25 - €229.50

Estimated Earnings Date

N/A

Dividend

€0.00

Beta (Volatility)

-0.14 (Low)

Price

€216.00

Volume

Open

€208.40

Previous Close

€216.00

Daily Range

€208.40 - €216.60

52-Week Range

€106.25 - €229.50

Estimated Earnings Date

N/A

J7Z News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Jazz Pharmaceuticals Plc

Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland.

Industry

Pharmaceuticals

Sector

Health Care

Employees

2,890

CEO

Renée D. Galá, MBA

Website

www.jazzpharma.com

J7Z Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

21.92%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

5.77%

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

€13.98B

Shares Outstanding

64.91M

Volume

Avg. Volume

41.985

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Jazz Pharmaceuticals Plc Performance Analysis

Jazz Pharmaceuticals Plc annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	EUR 3,481,887,180	33.0%
2023	2023-12-31	EUR 3,546,525,450	1.9%
2024	2024-12-31	EUR 3,761,657,365	6.1%
2025	2025-12-31	EUR 3,781,383,464	0.5%

Jazz Pharmaceuticals Plc annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	EUR -3.41	-27.0%
2023	2023-12-31	EUR 5.64	N/A
2024	2024-12-31	EUR 8.00	41.7%
2025	2025-12-31	EUR -5.17	N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

€1.04K

+1.1%

Gross Profit

€792.89

+1.2%

Gross Margin

76.30%

+1.0%

Market Cap

€13.98B

N/A

Market Cap/Employee

€4.56

N/A

Employees

2,890

N/A

Net Income

€165.82

-0.3%

EBITDA

€433.73

+1.3%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

€5.27K

-6.5%

Total Debt

€3.86K

+0.8%

Accounts Receivable

€770.49

+1.3%

Inventory

€387.47

+0.9%

Long Term Debt

€2.96K

+0.8%

Short Term Debt

€901.51

+1.0%

Return on Assets

8.48%

-2.4%

Return on Invested Capital

0.62%

+0.0%

Free Cash Flow

€344.02

+8.9%

Operating Cash Flow

€359.69

+7.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

^GSPCS&P 500

^GSPCS&P 500$7,684.24-0.00%

^DJIDJI

^DJIDJI$53,254.61-0.01%

^IXICNASDAQ

^IXICNASDAQ$26,319.55-0.00%

BTCBitcoin

BTCBitcoin$78,890.00-0.00%

SPCXSPCX

SPCXSPCX$142.81+0.01%

AAPLAAPL

AAPLAAPL$315.25-0.01%

AMZNAMZN

AMZNAMZN$258.45-0.03%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

PCGPG&E

PCGPG&E$13.27-0.20%

NVDANvidia

NVDANvidia$220.78+0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$9.97+0.11%

CNHCNH Industrial

CNHCNH Industrial$11.83+0.01%

NUNu Holdings

NUNu Holdings$14.55+0.02%

BITOProShares Trust - ProShares Bitcoin ETF

BITOProShares Trust - ProShares Bitcoin ETF$10.63+0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.43-0.02%

Questions About J7Z

What is the current price of Jazz Pharmaceuticals Plc?

Jazz Pharmaceuticals Plc is trading at €216.00 per share.

What is the 52-week range for Jazz Pharmaceuticals Plc?

Over the past 52 weeks, Jazz Pharmaceuticals Plc has traded between €106.25 and €229.50.

How much debt does Jazz Pharmaceuticals Plc have?

As of the most recent reporting period, Jazz Pharmaceuticals Plc reported total debt of €3.86B.

How much cash does Jazz Pharmaceuticals Plc have on hand?

Jazz Pharmaceuticals Plc reported €1.42B in cash and cash equivalents in its most recent financial results.

What is Jazz Pharmaceuticals Plc’s dividend yield?

Jazz Pharmaceuticals Plc does not currently have a dividend yield.

Jazz Pharmaceuticals Plc(FRA) J7Z

Jazz Pharmaceuticals Plc Financials at a Glance

J7Z News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Jazz Pharmaceuticals Plc

J7Z Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Jazz Pharmaceuticals Plc Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About J7Z

What is the current price of Jazz Pharmaceuticals Plc?

What is the 52-week range for Jazz Pharmaceuticals Plc?

How much debt does Jazz Pharmaceuticals Plc have?

How much cash does Jazz Pharmaceuticals Plc have on hand?

What is Jazz Pharmaceuticals Plc’s dividend yield?

Premium Investing Services